Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: To investigate the association of prescript...

Full description

Saved in:
Bibliographic Details
Published in:JAMA
Main Authors: Inohara, Taku, Manandhar, Pratik, Kosinski, Andrzej S., Matsouaka, Roland A., Kohsaka, Shun, Mentz, Robert J., Thourani, Vinod H., Carroll, John D., Kirtane, Ajay J., Bavaria, Joseph E., Cohen, David J., Kiefer, Todd L., Gaca, Jeffrey G., Kapadia, Samir R., Peterson, Eric D., Vemulapalli, Sreekanth
Format: Artigo
Language:Inglês
Published: American Medical Association 2018
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583475/
https://ncbi.nlm.nih.gov/pubmed/30512100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18077
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items